Natural Alternatives International (NASDAQ:NAII) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com initiated coverage on shares of Natural Alternatives International (NASDAQ:NAII) in a report released on Thursday. The brokerage set a “buy” rating on the stock.

Natural Alternatives International Stock Performance

Shares of NAII stock opened at $4.25 on Thursday. The stock’s 50-day moving average is $4.49 and its two-hundred day moving average is $5.46. The firm has a market cap of $26.35 million, a price-to-earnings ratio of -2.95 and a beta of 0.60. Natural Alternatives International has a 1 year low of $4.11 and a 1 year high of $7.37. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.50 and a current ratio of 2.56.

Natural Alternatives International (NASDAQ:NAII) last issued its quarterly earnings data on Friday, September 27th. The company reported ($0.32) earnings per share (EPS) for the quarter. The firm had revenue of $29.49 million for the quarter. Natural Alternatives International had a negative return on equity of 10.23% and a negative net margin of 7.53%.

Hedge Funds Weigh In On Natural Alternatives International

An institutional investor recently raised its position in Natural Alternatives International stock. Geode Capital Management LLC grew its stake in shares of Natural Alternatives International, Inc. (NASDAQ:NAII) by 6.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 45,062 shares of the company’s stock after acquiring an additional 2,915 shares during the period. Geode Capital Management LLC owned about 0.73% of Natural Alternatives International worth $258,000 at the end of the most recent reporting period. 32.40% of the stock is currently owned by institutional investors and hedge funds.

About Natural Alternatives International

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.